EYLER CHARLES R 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Dec 5, 2017
Insider Transaction Report
Form 4
EYLER CHARLES R
SR. VP-FINANCE & TREASURER
Transactions
- Sale
COMMON STOCK
2017-12-01$105.46/sh−1,322$139,424→ 28,696 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 13, 2017 to satisfy tax obligations in connection with the vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.3696 to $105.7000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.